Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CNS Pharmaceuticals Inc. (CNSP) Message Board

Exposure to Wildfires Amplifies Cancer Risk, New S

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 367
(Total Views: 229)
Posted On: 06/01/2022 4:51:30 PM
Avatar
Posted By: NetworkNewsWire
Exposure to Wildfires Amplifies Cancer Risk, New Study Finds

Wildfires usually occur in every year in similar areas, with those who live near these regions being exposed to carcinogenic pollutants on a long-term basis. Now new research has discovered a higher incidence of brain tumors and lung cancer in individuals who have been exposed to wildfires.

The research, which was conducted by scientists from McGill University, tracked more than two million Canadians over a period of 20 years. It is the first study to assess how forest fire proximity may influence the risk of cancer. The researchers’ objective was to characterize the relationship between the incidence of several cancer outcomes and residential exposure to wildfires.

One of the researchers, Scott Weichenthal, a professor at McGill’s Department of Biostatistics, Epidemiology and Occupational Health, stated that little was known about the long-term effects that wildfires had on health. He also noted that the research had found that living in close proximity to wildfires increases the risk of some cancers.

The researchers found that individuals who lived within 50 km of wildfires over the last decade had a roughly 5% higher chance of developing lung cancer and a 10% higher chance of developing brain tumors in comparison to those who lived further away. The analysis was led by Jill Korsiak, who stated that wildfires were expected to become longer in duration, more severe and more prevalent in the future as the climate changes; she also noted that wildfires had been recognized as a health issue globally.

Korsiak further noted that wildfires emitted pollutants that were carcinogenic to humans, which suggested that being exposed to them could heighten the risk of cancer in humans. Weichenthal added that wildfires also polluted indoor, soil and aquatic environments as well as air quality. He explained that pollutants such as hydrocarbons and heavy metals persisted in the environment for extended periods, which meant that being exposed to harmful pollutants in the environment could continue even after active burning had ceased.

In their report, the researchers noted that more research needs to be conducted in order to understand the complicated mixture of pollutants that were released during wildfires into the environment. They added that further work was also required to develop long-term estimates of the chronic effects that wildfires had on human health.

The study’s findings were reported in the “Lancet Planetary Health.” Other researchers involved in the study include Michal Abrahamowic, Richard Burnett, Tanya Christidis and Lauren Pinault. The study was funded by Fonds de recherche du Quebec and the Canadian Institute for Health Research.

The rising toll of various brain cancers has led companies such as CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to devote significant resources toward the quest for the next generation of therapeutics that will offer better outcomes for patients affected by the oncologic indications affecting the brain.

NOTE TO INVESTORS: The latest news and updates relating to CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are available in the company’s newsroom at https://ibn.fm/CNSP

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer




(0)
(0)




CNS Pharmaceuticals Inc. (CNSP) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us